Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Scott Randal W.
Over the trailing 90 days, Scott Randal W. (Director at BridgeBio Pharma, Inc.) traded $839K of stock (net selling $504K) in BBIO, per 6 SEC Form 4 transactions.
- Role
- Director
- Companies
- BBIO
- Window
- Trailing 90 days · 6 transactions · CIK 1337801
- Net activity
- −$504K ($168K bought · $671K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 6 | $168K | $671K | −$504K |
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-05-15 | BBIO | Sell | 200 | $14K | Open market or private sale |
| 2026-05-15 | BBIO | Sell | 10.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-15 | BBIO | Buy | 10.0K | $168K | Exercise or conversion of derivative security |
| 2026-05-15 | BBIO | Sell | 6.2K | $413K | Open market or private sale |
| 2026-05-15 | BBIO | Sell | 2.1K | $141K | Open market or private sale |
| 2026-05-15 | BBIO | Sell | 1.5K | $103K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Scott's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.